Europe has taken a lead in the development of IGMT, an high-quality integrated ImMunoGeneTics database, unique in the world, specialised in the complex gene families of the specific immune response in human and other vertebrates: Immunoglobulins (Ig), T cell Receptors (TcR) and MHC. LIGM-CNRS (F), EBI (UK),ICRF (UK), BPRC (NL) and EUROGENTEC (B) propose to expand IMGT into an information system which will integrate and provide a common access to all protein, polymorphism and structural Ig, TcR and MHC data. By management of the enormous complexity of the immunogenetics data, IMGT will be crucial for functional and comparative genomics of the immune system, biotechnologies, and therapeutic approaches such as vaccines, grafts, and immunotherapies. IMGT will be of immense value for Medicine, Biotechnology and the European Pharmaceutical Industry, and will considerably help to strengthen Europe's role in these areas.
Funding SchemeCSC - Cost-sharing contracts
OX3 9DU Oxford/headington
CB10 1SD Saffron Walden
2288 GJ Rijswijk Zh